Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference

WALTHAM, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that management will present at TD Cowen’s 45^th Annual Health Care Conference on Monday, March 3, 2025 at 9:50am ET in Boston.

Read more at globenewswire.com